Search Results - "Gomez, Roy"

Refine Results
  1. 1

    Stigma associated with genetic testing for rare diseases-causes and recommendations by Baynam, Gareth, Gomez, Roy, Jain, Ritu

    Published in Frontiers in genetics (04-04-2024)
    “…Rare disease (RD) is a term used to describe numerous, heterogeneous diseases that are geographically disparate. Approximately 400 million people worldwide…”
    Get full text
    Journal Article
  2. 2

    Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review by Gomez, Roy, Ahmed, S Faisal, Maghnie, Mohamad, Li, Dejun, Tanaka, Toshiaki, Miller, Bradley S

    Published in Frontiers in endocrinology (Lausanne) (01-03-2022)
    “…Pediatric patients with growth hormone deficiency (GHD) are currently treated with daily injections of recombinant human growth hormone (rhGH) to promote…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004–2015) by Ben-Ari, Tal, Chodick, Gabriel, Shalev, Varda, Goldstein, Dalit, Gomez, Roy, Landau, Zohar

    Published in Frontiers in pediatrics (20-08-2021)
    “…Objective: To assess a decade of growth hormone (GH) treatment patterns and outcomes in a real-world setting in Israel using a state-of-the-art computerized…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY by van der Lely, A. J, Biller, Beverly M. K, Brue, Thierry, Buchfelder, Michael, Ghigo, Ezio, Gomez, Roy, Hey-Hadavi, Judith, Lundgren, Frida, Rajicic, Natasa, Strasburger, Christian J, Webb, Susan M, Kołtowska-Häggström, Maria

    Published in Pharmacotherapy (01-05-2012)
    “…Context: Pegvisomant is a GH receptor antagonist. The ACROSTUDY is a global safety surveillance study of long-term treatment of acromegaly with pegvisomant…”
    Get full text
    Journal Article
  9. 9

    Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience by Salvatori, Roberto, Maffei, Pietro, Webb, Susan M., Brue, Thierry, Loftus, Jane, Valluri, Srinivas Rao, Gomez, Roy, Wajnrajch, Michael P., Fleseriu, Maria

    Published in Pituitary (01-06-2022)
    “…Purpose To report the effects of pegvisomant (PEGV) treatment on patient-reported outcomes in acromegaly patients. Methods We conducted an extension study of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy by Brue, Thierry, Lindberg, Anders, Jan van der Lely, Aart, Akerblad, Ann Charlotte, Koltowska-Häggström, Maria, Gomez, Roy, Droste, Michael, Hey-Hadavi, Judith, Strasburger, Christian J, Camacho-Hübner, Cecilia

    Published in Endocrine (01-03-2019)
    “…Purpose To explore the effects of pegvisomant (PEGV) on glucose metabolism in patients with acromegaly within ACROSTUDY, an international, observational,…”
    Get full text
    Journal Article
  16. 16

    Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy by Basmaison, Odile, Ranchin, Bruno, Zouater, Hichem, Robertson, Anna, Gomez, Roy, Koppiker, Nandan

    Published in Annales d'endocrinologie (01-09-2019)
    “…AbstractObjectiveTo evaluate safety and efficacy of recombinant human growth hormone treatment in children on long-term glucocorticoid therapy. MethodsA 5-year…”
    Get full text
    Journal Article
  17. 17

    Propuesta de un sistema para bebederos automatizado en fincas de ganado en Veraguas by Gomez, Roy, Pinzon, Cristian

    “…La escasez del agua obliga a reiterar nuevamente una llamada a la moderación de consumo por parte de la población. Debido a la sequía, cientos de productores…”
    Get full text
    Conference Proceeding
  18. 18
  19. 19
  20. 20

    Improving Treatment Outcomes Through Personalised Medicine : Assessment of Disease Activity in Acromegaly by Gomez, Roy

    Published 01-01-2017
    “…Purpose Personalised Medicine (PM), also known as stratified medicine has been known to improve treatment outcomes in a wide variety of disease area settings…”
    Get full text
    Dissertation